BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Monday, April 13, 2026
Breaking News: Best of BioWorld Science: Q1
See today's BioWorld Science
Home
» Peptide P92 targets
A. baumannii
OmpA, reducing pathogenicity and exhibiting antibacterial activity
To read the full story,
subscribe
or
sign in
.
Infection
Peptide P92 targets
A. baumannii
OmpA, reducing pathogenicity and exhibiting antibacterial activity
Dec. 5, 2024
Researchers from the Fourth Military Medical University (Air Force Medical University) have identified novel antimicrobial molecules.
BioWorld Science
Infection
Peptide